Search

Mauricio J Reginato

from Philadelphia, PA
Age ~58

Mauricio Reginato Phones & Addresses

  • 769 N 24Th St, Philadelphia, PA 19130 (215) 978-0272
  • 324 Delancey St #2, Philadelphia, PA 19106 (215) 574-0199
  • Phila, PA
  • 517 Valley View Rd, Merion Sta, PA 19066 (610) 949-0171 (610) 949-0172
  • Merion Station, PA
  • Lake Harmony, PA
  • Narberth, PA
  • Brookline, MA

Resumes

Resumes

Mauricio Reginato Photo 1

Co-Leader, Program In Breast Cancer

View page
Location:
Collegeville, PA
Industry:
Research
Work:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Co-Leader, Program In Breast Cancer

Harvard Medical School 1998 - 2004
Post-Doctoral Fellow

Drexel University College of Medicine 1998 - 2004
Professor

University of Pennsylvania Sep 1992 - May 1998
Phd Candidate

Smithkline Beecham 1989 - 1992
Associate Scientist
Education:
Harvard Medical School 1998 - 2004
University of Pennsylvania School of Medicine 1992 - 1998
Doctorates, Doctor of Philosophy, Philosophy, Pharmacology
Penn State University 1985 - 1989
Bachelors, Bachelor of Science, Biology
Skills:
Molecular Biology
Cell Biology
Cell Culture
Western Blotting
Biochemistry
Cancer Research
Cell Signaling
Immunofluorescence
Tissue Culture
Fluorescence Microscopy
Animal Models
Molecular Cloning
Confocal Microscopy
Cancer
Transfection
Immunoprecipitation
In Vivo
Languages:
Spanish
Mauricio Reginato Photo 2

Mauricio Reginato

View page
Work:
Drexel University College of Medicine
Assistant Professor

Publications

Us Patents

Methods For Treating Neoplastic Disease Targeting O-Linked N-Acetylglucosamine Modifications Of Cellular Protein

View page
US Patent:
20110171203, Jul 14, 2011
Filed:
Oct 3, 2008
Appl. No.:
12/679562
Inventors:
Mauricio J. Reginato - Merion Station PA, US
Keith Vosseller - Philadelphia PA, US
Assignee:
Philadelphia Health & Education Corporation d/b/a Drexel University College of Medicine - Philadelphia PA
International Classification:
A61K 39/395
A61P 35/00
A61K 31/7088
C12Q 1/02
C12Q 1/68
C12Q 1/48
US Classification:
4241301, 514 44 A, 435 29, 435 614, 435 15, 435 613
Abstract:
Methods for treating a neoplastic disease in a mammalian subject are provided. The method provides administering an inhibitor of O-GlcNAc transferase in an amount effective to reduce or eliminate the neoplastic disease in the mammalian subject. Method for diagnosing a risk factor for a neoplastic disease in a mammalian subject and methods for identifying a test compound which inhibits a hexosamine signaling pathway in a cell or tissue are provided.
Mauricio J Reginato from Philadelphia, PA, age ~58 Get Report